GS vs ORMP
Goldman Sachs Group Inc (GS) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
GS does not have a complete income-statement cache yet.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
GS currently screens at market cap $324.25B and trailing P/E 20.1. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the GS and ORMP stock pages for the full models.
Not investment advice.